Efavirenz, Lamivudine And Tenofovir Disoproxil Fumarate 42385-0929
Product NDC
42385-0929- Manufacturer
- Laurus Labs Limited
- Dosage Form
- Tablet, Film Coated
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- May 14, 2020
- Listing Expires
- December 31, 2026
- Application
- ANDA213038
Need to source Efavirenz, Lamivudine And Tenofovir Disoproxil Fumarate? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Efavirenz | 400 mg/1 |
| Lamivudine | 300 mg/1 |
| Tenofovir Disoproxil Fumarate | 300 mg/1 |
Drug Class
Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
Packaging Options(6)
180 TABLET, FILM COATED in 1 BOTTLE (42385-929-18)
30 TABLET, FILM COATED in 1 BOTTLE (42385-929-30)
30 TABLET, FILM COATED in 1 BOTTLE (42385-929-31)
180 TABLET, FILM COATED in 1 BOTTLE (42385-929-82)
90 TABLET, FILM COATED in 1 BOTTLE (42385-929-90)
90 TABLET, FILM COATED in 1 BOTTLE (42385-929-91)
External Resources